Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0005064,
umls-concept:C0007412,
umls-concept:C0007452,
umls-concept:C0010453,
umls-concept:C0016904,
umls-concept:C0030685,
umls-concept:C0205112,
umls-concept:C0376604,
umls-concept:C0391871,
umls-concept:C0441472,
umls-concept:C0521428,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1963578
|
pubmed:dateCreated |
1990-3-6
|
pubmed:abstractText |
Effects of benzodiazepines were investigated on the gamma-aminobutyric acid-induced modulation of the basal and veratridine-evoked catecholamine release from cultured bovine adrenal chromaffin cells. GABA by itself, caused catecholamine release and facilitated veratridine-evoked catecholamine release. Midazolam enhanced the GABA-evoked catecholamine release in a dose-related fashion and further facilitated the enhancement by GABA of the veratridine-evoked catecholamine release. Clonazepam, a selective central-type benzodiazepine receptor agonist, also enhanced the GABA-induced catecholamine release, whereas ethyl-beta-carboline-3-carboxylate, an inverse agonist of the benzodiazepine receptor, reduced the GABA-evoked catecholamine release. The dose-response curve of the GABA-evoked catecholamine release was shifted to the left by midazolam without affecting the maximal response to GABA. Facilitation by midazolam and clonazepam of the GABA action or inhibition by ethyl-beta-carboline-3-carboxylate was antagonized by RO15-1788, which by itself had no effect on the basal or GABA- and veratridine-evoked catecholamine release. These results suggest that the central-type benzodiazepine receptor participates in the GABAergic modulation of the catecholamine release from adrenal chromaffin cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Anxiety Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Catecholamines,
http://linkedlifedata.com/resource/pubmed/chemical/Flumazenil,
http://linkedlifedata.com/resource/pubmed/chemical/Midazolam,
http://linkedlifedata.com/resource/pubmed/chemical/Veratridine,
http://linkedlifedata.com/resource/pubmed/chemical/Veratrine,
http://linkedlifedata.com/resource/pubmed/chemical/gamma-Aminobutyric Acid
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0301-4533
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
300
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
254-64
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2575888-Adrenal Glands,
pubmed-meshheading:2575888-Animals,
pubmed-meshheading:2575888-Anti-Anxiety Agents,
pubmed-meshheading:2575888-Basal Ganglia,
pubmed-meshheading:2575888-Catecholamines,
pubmed-meshheading:2575888-Cattle,
pubmed-meshheading:2575888-Cells, Cultured,
pubmed-meshheading:2575888-Chromaffin System,
pubmed-meshheading:2575888-Electric Stimulation,
pubmed-meshheading:2575888-Flumazenil,
pubmed-meshheading:2575888-Midazolam,
pubmed-meshheading:2575888-Veratridine,
pubmed-meshheading:2575888-Veratrine,
pubmed-meshheading:2575888-gamma-Aminobutyric Acid
|
pubmed:articleTitle |
Benzodiazepines facilitate the stimulatory action of gamma-aminobutyric acid (GABA) on basal and veratridine-evoked catecholamine release from cultured bovine adrenal chromaffin cells.
|
pubmed:affiliation |
Department of Pharmacology, Hiroshima University School of Dentistry, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|